Search





Search





Markets
/
Stocks
/
obio
/

Orchestra Biomed Holdings Inc

OBIO

Add to Watchlist

3.740USD

+0.100+2.75%

Close 07-24 16:00（ET）Quotes delayed by 15 min

223.95MMarket Cap

LossP/E TTM

Orchestra Biomed Holdings Inc

3.740

+0.100+2.75%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

OBIO Cash Flow Statement

You can access the annual and quarterly cash flow statements of Orchestra Biomed Holdings Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-33.41%-22.17M

83.23%-2.27M

-6.20%-14.55M

-52.14%-15.53M

-26.70%-16.62M

-23.36%-13.54M

-33.24%-13.70M

2.71%-10.21M

8.81%-13.11M

-25.50%-10.97M

-41.70%-10.28M

-31.70%-10.49M

-170.12%-14.38M

-89.88%-8.74M

-50.29%-7.26M

-80.61%-7.96M

4.69%-5.32M

---4.61M

---4.83M

---4.41M

---5.59M

Net income from continuing operations

-10.32%-20.69M

138.66%6.25M

-35.02%-20.83M

-21.17%-19.36M

-39.31%-18.75M

-26.03%-16.16M

-15.85%-15.43M

-32.66%-15.98M

-23.06%-13.46M

-31.47%-12.82M

-29.51%-13.32M

-53.51%-12.05M

-90.96%-10.94M

-20.89%-9.75M

-95.59%-10.28M

-27.49%-7.85M

-61.97%-5.73M

---8.06M

---5.26M

---6.16M

---3.54M

Operating gains losses

8.43%90.00K

-2.38%82.00K

6.58%81.00K

9.46%81.00K

12.16%83.00K

16.67%84.00K

7.04%76.00K

1.37%74.00K

4.23%74.00K

2.86%72.00K

31.48%71.00K

46.00%73.00K

47.92%71.00K

45.83%70.00K

17.39%54.00K

13.64%50.00K

11.63%48.00K

--48.00K

--46.00K

--44.00K

--43.00K

Other non-cash items

1691.36%1.45M

19.52%1.19M

957.33%643.00K

194.84%147.00K

115.46%81.00K

47.26%994.00K

91.35%-75.00K

82.12%-155.00K

39.42%-524.00K

263.83%675.00K

-566.13%-867.00K

-197.09%-867.00K

-562.57%-865.00K

-1036.36%-412.00K

295.74%186.00K

1800.00%893.00K

306.52%187.00K

--44.00K

--47.00K

--46.00K

Change in working capital

-270.00%-3.66M

-801.03%-12.28M

497.65%2.54M

-88.34%358.00K

46.02%-990.00K

-1075.00%-1.36M

-204.24%-639.00K

401.80%3.07M

58.47%-1.83M

-223.40%-116.00K

115.09%613.00K

208.32%612.00K

-1566.42%-4.42M

-97.25%94.00K

168.35%285.00K

-145.49%-565.00K

83.59%-265.00K

--3.42M

---417.00K

--1.24M

---1.61M

-Change in receivables

266.67%11.00K

-213.16%-43.00K

188.57%31.00K

146.15%6.00K

-90.63%3.00K

392.31%38.00K

-141.18%-35.00K

86.32%-13.00K

60.00%32.00K

---13.00K

631.25%85.00K

-9400.00%-95.00K

-52.38%20.00K

-100.00%0.00

-157.14%-16.00K

97.50%-1.00K

-8.70%42.00K

--13.00K

--28.00K

---40.00K

--46.00K

-Change in inventory

-13.16%33.00K

-8.33%55.00K

-10.37%-181.00K

-208.89%-49.00K

22.58%38.00K

850.00%60.00K

-500.00%-164.00K

-16.67%45.00K

-29.55%31.00K

-114.81%-8.00K

120.81%41.00K

153.47%54.00K

22.22%44.00K

-11.48%54.00K

-146.25%-197.00K

-818.18%-101.00K

16.13%36.00K

--61.00K

---80.00K

---11.00K

--31.00K

-Change in prepaid expenses

-1462.86%-477.00K

211.05%593.00K

123.56%139.00K

0.00%113.00K

158.33%35.00K

-65.33%-534.00K

-322.64%-590.00K

-85.40%113.00K

95.99%-60.00K

-997.22%-323.00K

2550.00%265.00K

238.96%774.00K

-2179.17%-1.50M

300.00%36.00K

150.00%10.00K

-798.39%-557.00K

-29.41%72.00K

--9.00K

---20.00K

---62.00K

--102.00K

-Change in payables and accrued expense

-1413.86%-3.06M

179.49%566.00K

176.95%3.41M

-70.75%1.09M

84.18%-202.00K

-244.42%-712.00K

84.43%1.23M

378.31%3.73M

28.86%-1.28M

-53.40%493.00K

-58.82%668.00K

65.74%779.00K

-988.61%-1.79M

58.38%1.06M

92.64%1.62M

168.57%470.00K

133.28%202.00K

--668.00K

--842.00K

--175.00K

---607.00K

-Change in other current liabilities

----

-17183.12%-13.31M

10.21%-721.00K

-6.21%-667.00K

-47.28%-732.00K

12.50%-77.00K

-196.31%-803.00K

13.74%-628.00K

51.23%-497.00K

90.55%-88.00K

72.52%-271.00K

-217.90%-728.00K

-42.32%-1.02M

-134.88%-931.00K

16.93%-986.00K

-119.41%-229.00K

39.68%-716.00K

--2.67M

---1.19M

--1.18M

---1.19M

Cash from non-recurring investing activities

Cash from operating activities

-33.41%-22.17M

83.23%-2.27M

-6.20%-14.55M

-52.14%-15.53M

-26.70%-16.62M

-23.36%-13.54M

-33.24%-13.70M

2.71%-10.21M

8.81%-13.11M

-25.50%-10.97M

-41.70%-10.28M

-31.70%-10.49M

-170.12%-14.38M

-89.88%-8.74M

-50.29%-7.26M

-80.61%-7.96M

4.69%-5.32M

---4.61M

---4.83M

---4.41M

---5.59M

Investing cash flow

Net cash from continuing investing activities

64.29%184.00K

-95.34%33.00K

355.88%310.00K

-68.22%34.00K

1300.00%112.00K

23700.00%708.00K

257.89%68.00K

296.30%107.00K

-77.14%8.00K

-105.56%-3.00K

-91.52%19.00K

-89.85%27.00K

-25.53%35.00K

-56.45%54.00K

322.64%224.00K

--266.00K

-51.55%47.00K

--124.00K

--53.00K

--0.00

--97.00K

Capital expenditures

64.29%184.00K

-95.34%33.00K

355.88%310.00K

-68.22%34.00K

1300.00%112.00K

--708.00K

257.89%68.00K

296.30%107.00K

-77.14%8.00K

----

-91.52%19.00K

-89.85%27.00K

-25.53%35.00K

-56.45%54.00K

322.64%224.00K

--266.00K

-51.55%47.00K

--124.00K

--53.00K

--0.00

--97.00K

Net cash flow from disposal of fixed assets

64.29%184.00K

-95.34%33.00K

355.88%310.00K

-68.22%34.00K

1300.00%112.00K

23700.00%708.00K

257.89%68.00K

296.30%107.00K

-77.14%8.00K

-105.56%-3.00K

-91.52%19.00K

-89.85%27.00K

-25.53%35.00K

-56.45%54.00K

322.64%224.00K

--266.00K

-51.55%47.00K

--124.00K

--53.00K

--0.00

--97.00K

Net cash flow from investment products

-19.90%10.50M

-480.59%-17.68M

-6223.84%-38.27M

55.64%16.39M

123.39%13.11M

-109.19%-3.04M

-95.18%625.00K

29.29%10.53M

113.49%5.87M

152.35%33.15M

--12.97M

4015.87%8.14M

---43.49M

-29629.11%-63.32M

-100.00%0.00

-103.28%-208.00K

-100.00%0.00

---213.00K

--6.33M

--840.00K

Net cash flow from other investing activities

----

100.00%0.00

--0.00

----

---602.00K

----

Cash from non-current investing activities

Net cash flow from investing activities

-20.62%10.32M

-371.94%-17.71M

-7027.11%-38.58M

56.91%16.36M

121.79%13.00M

-111.32%-3.75M

-95.70%557.00K

28.41%10.42M

113.46%5.86M

152.31%33.15M

5879.91%12.95M

1812.66%8.12M

-92514.89%-43.53M

-18706.23%-63.38M

-103.57%-224.00K

-107.48%-474.00K

-106.33%-47.00K

---337.00K

--6.28M

--6.33M

--743.00K

Financing cash flow

Cash flow from continuous financing activities

1967.23%5.53M

-9.23%12.66M

408.13%76.40M

-350.29%-428.00K

-1744.44%-296.00K

230.39%13.95M

375775.00%15.04M

98.84%171.00K

-99.97%18.00K

-110.14%-10.70M

100.16%4.00K

-99.90%86.00K

129.45%56.82M

-412.59%-5.09M

-149.80%-2.50M

8708.10%86.08M

2576.40%24.76M

---993.00K

---1.00M

Net cash flow from debt Issuance/repayment

----

-100.00%0.00

----

238.26%15.00M

----

---10.85M

--0.00

-100.00%0.00

100.00%0.00

555.40%4.55M

0.00%-1.00M

---1.00M

Net cash flow from common stock issuance/repurchase

----

--1.54M

284.30%57.78M

----

--0.00

--15.04M

----

Net cash flow from preferred stock issuance/repurchase

----

--12.56M

----

-100.00%0.00

--0.00

--82.55M

--27.28M

--0.00

----

Proceeds from stock option exercised by employees

-71.43%26.00K

-100.00%0.00

--0.00

-100.00%0.00

405.56%91.00K

-66.67%51.00K

-100.00%0.00

167.19%171.00K

80.00%18.00K

--153.00K

0.00%4.00K

-30.43%64.00K

-60.00%10.00K

-100.00%0.00

--4.00K

--92.00K

--25.00K

--3.00K

--0.00

Proceeds from issuance of warrants

----

100.00%0.00

--0.00

340.00%22.00K

-98.65%1.00K

-350.00%-10.00K

--0.00

--5.00K

--74.00K

--4.00K

--0.00

Net cash flow from other financing activities

1521.45%5.50M

-30.43%-1.44M

23.82%18.62M

---428.00K

---387.00K

---1.10M

--15.04M

----

100.00%0.00

3626.38%56.81M

---5.08M

---2.50M

---1.12M

---1.61M

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

1967.23%5.53M

-9.23%12.66M

408.13%76.40M

-350.29%-428.00K

-1744.44%-296.00K

230.39%13.95M

375775.00%15.04M

98.84%171.00K

-99.97%18.00K

-110.14%-10.70M

100.16%4.00K

-99.90%86.00K

129.45%56.82M

-412.59%-5.09M

-149.80%-2.50M

8708.10%86.08M

2576.40%24.76M

---993.00K

---1.00M

Net cash flow

Beginning cash balance

55.83%34.69M

64.08%42.01M

-20.93%18.75M

-21.33%18.35M

-27.15%22.26M

34.21%25.61M

44.51%23.71M

24.76%23.32M

54.46%30.56M

-80.33%19.08M

-84.66%16.41M

-36.26%18.70M

99.07%19.78M

511.07%97.00M

593.50%106.97M

102.28%29.33M

-51.15%9.94M

--15.87M

--15.43M

--14.50M

--20.34M

Current period cash flow changes

-61.59%-6.32M

-118.96%-7.32M

1129.55%23.26M

3.08%401.00K

45.92%-3.91M

-129.13%-3.34M

-29.11%1.89M

117.02%389.00K

-564.37%-7.24M

114.87%11.48M

126.75%2.67M

-102.94%-2.29M

-105.62%-1.09M

-1200.94%-77.21M

-2327.23%-9.98M

8293.73%77.64M

431.90%19.39M

---5.94M

--448.00K

--925.00K

---5.84M

Ending cash balance

54.61%28.37M

55.83%34.69M

64.08%42.01M

-20.93%18.75M

-21.33%18.35M

-27.15%22.26M

34.21%25.61M

44.51%23.71M

24.76%23.32M

54.46%30.56M

-80.33%19.08M

-84.66%16.41M

-36.26%18.70M

99.07%19.78M

511.07%97.00M

593.50%106.97M

102.28%29.33M

--9.94M

--15.87M

--15.43M

--14.50M

Free cash flow

-33.62%-22.35M

83.83%-2.30M

-7.93%-14.86M

-50.89%-15.56M

-27.48%-16.73M

-29.82%-14.25M

-33.66%-13.77M

1.94%-10.31M

8.98%-13.12M

-24.73%-10.97M

-37.71%-10.30M

-27.77%-10.52M

-168.40%-14.42M

-86.04%-8.80M

-53.25%-7.48M

-86.64%-8.23M

5.49%-5.37M

---4.73M

---4.88M

---4.41M

---5.68M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Orchestra Biomed Holdings Inc Generate?



Orchestra Biomed Holdings Inc generated -48.96M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Orchestra Biomed Holdings Inc's Operating Cash Flow Change Year Over Year?



Orchestra Biomed Holdings Inc's operating cash flow increased by 3.15% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Orchestra Biomed Holdings Inc Spend on Capital Expenditures?



Orchestra Biomed Holdings Inc spent 489.00K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Orchestra Biomed Holdings Inc's Financing Cash Flow Changed?



Orchestra Biomed Holdings Inc used 88.33M in financing activities in the latest quarter.

What is free cash flow and why does it matter for OBIO?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Orchestra Biomed Holdings Inc’s free cash flow in the latest quarter?



Free cash flow was -49.45M reflecting a 3.88% change from the previous year.